UMaine biotech start-up Neuright to be featured in March 15 Innovation Blender

Kristy Townsend, University of Maine alumna and former faculty member, and cofounder of Neuright Inc., will lead a discussion, “Neuright Inc. Tackles Peripheral Neuropathy — Catch It Early, Fix It Fast,” as part of the Innovation Blender series sponsored by MaineHealth Innovation and The Roux Institute.

Neuright is a UMaine biotech start-up and academic spin-out company that has commercialized a new patent-pending theragnostic medical device for peripheral neuropathy, a condition of nerve death in tissues and organs that is common with aging, diabetes, and more than 30 other diseases and disorders. Read more

Related Posts

Bar Harbor approves Jackson Lab’s $33M expansion for rare disease research

The Bar Harbor Planning Board has approved a plan by the Jackson Laboratory to build a 20,000-square-foot expansion to its Rare Disease Translational...

22 August 2024

Bigelow lab receives $7 million for algae research, business development

Researchers at Bigelow Laboratory for Ocean Sciences believe algae can make a big splash in the agricultural, aquaculture and pharmaceutical industries,...

21 August 2024

Should Maine create a public medical school? UMaine System will study the question

The University of Maine System said this week it will work with a national consultant to study the feasibility of launching the state’s...

21 August 2024